These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7469025)

  • 21. [THERAPEUTIC TRIAL OF AN 0.01 P. 100 FLUOCINOLONE ACETONIDE OINTMENT UNDER HERMETIC DRESSINGS IN PSORIASIS].
    TEMIME P; PRIVAT Y; BURNOD A; LATOURELLE P
    Bull Soc Fr Dermatol Syphiligr; 1963; 70():915-6. PubMed ID: 14159326
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of Two Novel Hydroperoxide Impurities in Fluocinolone Acetonide Topical Solution by Liquid Chromatography Mass Spectrometry.
    Kavitapu D; Jaishetty N; Maruthapillai A; Murty JNSRC
    J Chromatogr Sci; 2024 May; 62(5):414-425. PubMed ID: 36682009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [TREATMENT OF PSORIASIS WITH FLUOCINOLONE ACETONIDE 0.01 PER CENT BY THE OCCLUSIVE METHOD].
    MILLANGUTIERREZ J
    Medicina (Mex); 1964 Mar; 44():111-4. PubMed ID: 14138600
    [No Abstract]   [Full Text] [Related]  

  • 24. DOUBLE-BLIND COMPARATIVE TRIAL OF BETAMETHASONE 17-VALERATE AND FLUOCINOLONE ACETONIDE OINTMENTS.
    BUCKLEY DB
    J Ir Med Assoc; 1964 Aug; 55():45-7. PubMed ID: 14179703
    [No Abstract]   [Full Text] [Related]  

  • 25. A new corticoid for topical therapy. Fluocinolone acetonide.
    SCHOLTZ JR
    Calif Med; 1961 Oct; 95(4):224-6. PubMed ID: 13909153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [FLUOCINOLONE ACETONIDE (0.01 PER CENT) UNDER OCCLUSIVE DRESSING: THERAPEUTIC VALUE IN DERMATOLOGY OF THIS NEW PRODUCT IN WEAK CONCENTRATION].
    BAZEX A; DUPRE A; CHRISTOL B
    Presse Med (1893); 1964 Oct; 72():2387-8. PubMed ID: 14187775
    [No Abstract]   [Full Text] [Related]  

  • 27. [OCCLUSIVE TREATMENT OF DERMATITIS HERPETIFORMIS, PEMPHIGOID DISEASES AND PEMPHIGUS VULGARIS WITH FLUOCINOLONE ACETONIDE].
    BJOERNBERG A; HELLGREN L
    Acta Allergol; 1964; 19():421-6. PubMed ID: 14218383
    [No Abstract]   [Full Text] [Related]  

  • 28. Triamcinolone and fluocinolone acetonide ointments in atopic eczema.
    PETERKIN GA; MORLEY WN; CHALMERS D
    Br Med J; 1962 May; 1(5289):1392. PubMed ID: 14485717
    [No Abstract]   [Full Text] [Related]  

  • 29. [EXPERIENCES WITH A NEW LOCAL CORTICOSTEROID (FLUOCINOLINE ACETONIDE)].
    HARTMANN W
    Ther Ggw; 1963 Oct; 102():1203-8. PubMed ID: 14096251
    [No Abstract]   [Full Text] [Related]  

  • 30. Corticosteroid ointments: comparison by two human bioassays.
    Burdick KH; Haleblian JK; Poulsen BJ; Cobner SE
    Curr Ther Res Clin Exp; 1973 May; 15(5):233-42. PubMed ID: 4196783
    [No Abstract]   [Full Text] [Related]  

  • 31. [EFFECT OF SYNALAR, A FLUOCINOLOE ACETONIDE CONTAINING PREPARATION, ON SOME CHRONIC SKIN DISEASES].
    HORKAY I; MESZAROS C; DAROCZY P
    Orv Hetil; 1965 Jul; 106():1273-6. PubMed ID: 14322207
    [No Abstract]   [Full Text] [Related]  

  • 32. THE TOPICAL USE OF FLUOCINOLONE ACETONIDE CREAM FOR RELIEF OF VULVAR AND PERINEAL PRURITUS.
    ARNO IC; WAPNER PM; BROWNSTEIN IE
    J Albert Einstein Med Cent (Phila); 1963 Jul; 11():224-7. PubMed ID: 14044068
    [No Abstract]   [Full Text] [Related]  

  • 33. Decrease of urinary corticosteroids following application of fluocinolone acetonide under an occlusive dressing.
    SCOGGINS RB
    J Invest Dermatol; 1962 Dec; 39():473-4. PubMed ID: 13992475
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic discoid lupus erythematosus with fluocinolone acetonide ointment.
    BJORNBERG A; HELLGREN L
    Br J Dermatol; 1963 Apr; 75():156-60. PubMed ID: 13971327
    [No Abstract]   [Full Text] [Related]  

  • 35. IMPROVED DERMATOLOGIC THERAPY WITH FLUOCINOLONE ACETONIDE, A NEW TOPICAL STEROID.
    FELDMAN I
    J Am Osteopath Assoc; 1963 Nov; 63():257-60. PubMed ID: 14059545
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of mycosis fungoides with various strengths of fluocinolone acetonide cream.
    Farber EM; Zackheim HS; McClintock RP; Cox AJ
    Arch Dermatol; 1968 Feb; 97(2):165-72. PubMed ID: 5636051
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences with fluocinolone acetonide in burns].
    Wittels W; Gmeinder A
    Med Welt; 1967 May; 21():1311-2 passim. PubMed ID: 5612542
    [No Abstract]   [Full Text] [Related]  

  • 38. Necrosis in leg ulcers. Probable role of fluocinolone acetonide.
    Bjornberg A; Hellgren L
    Arch Dermatol; 1965 Jul; 92(1):52-3. PubMed ID: 11850953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of the therapeutic activity of a fluocinolone acetonide ointment].
    Pochy-Riano' R
    Omnia Med Ther; 1968; 46(4):849-57. PubMed ID: 4247010
    [No Abstract]   [Full Text] [Related]  

  • 40. TOPICAL FLUOCINOLONE WITH OCCLUSION IN PRETIBIAL MYXEDEMA.
    JONES BE; WILLIAMS RM
    Arch Dermatol; 1964 Sep; 90():305-6. PubMed ID: 14170604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.